Skip to content

APOTEEK ENGSBERGEN

Active Private limited companyfounded 1986active for 40 yearsEngsbergseweg 69, 3980 Tessenderlo-HamKBO/BCE: BE 0429.393.759 subsidiary of

Lifetime

19 annual accounts with figures on one time axis, 38 filings since 1987
peak of €94,629 in 2024
€70,331▼ 25.7%
lowest -€66,914 in 2017
€27,688▼ 50.8%
peak of €769,095 in 2015
€319,813▲ 9.5%
€1.0m▲ 268%
peak of 0.2 FTE in 2011
-not published
Board4 names since 2016
1 director
Owners
100%
Documentsfilings and deeds
30-08-202630 days late
2025abbreviated format
Gross margin from €94,629 to €70,331Result from €56,243 to €27,688Debts from €274,879 to €1.0mInvestments €535,869

Key points

from the 2025 annual accounts

Equity

€319,813 from €769,095 in 2015

Equity fell by 58% in 10 years.

Debts

€1.0m ▲ 268%
Financial debts
+0.4
Suppliers
+0.3
Other debts
+0.02

Debts rose by €735,522 in 2025.

Securities

€800,000

Mortgage mandates, new in 2025. 2.5 times equity · not in the 2024 accounts.

Investments

€535,869 20.1 times depreciation
202320242025

Green is investment, beige is depreciation. Machinery stands 24997.8% higher than in 2024.

Liquidity

1.74 was 4.78 in 2024

Short-term debts rose from €96,877 to €411,611.

Filings

38 annual accounts since 1987
AprilJune31 JulyOctober1990200020102020

Nine of the last ten came late. The 2019 accounts came in latest, 59 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 4,686 companies had the same profile as APOTEEK ENGSBERGEN has now. Each dot stands for 12 companies, two years later.

96.9%
were still trading
1.9%
stopped another way
1.1%
went bankrupt
  • Small
  • 20 years or older
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 4,686 companies, not a prediction for APOTEEK ENGSBERGEN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
  • 100%equity €756,041 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0429393759
changes role from manager to director acts as permanent representative · Director discharge: · General meeting of 05-10-2023 · Gazette deed
New manager appointed, resigned · acts as permanent representative · General meeting of 30-04-2017 · Gazette deed
General meeting of 14-12-2016 Gazette deed
All 52 events

Comparable companies

same main activity, similar in size and age
Company
APOTEEK ENGSBERGEN Tessenderlo-Ham €1.3m €70,331 24.0% -
APOTHEEK JANS Riemst €1.2m €83,468 12.6% 0.9
DALEMANS Buggenhout €1.2m €63,647 41.8% 1
NEVEUX Sint-Niklaas €1.3m €83,341 61.8% -
APOTHEEK BAETENS Evergem €1.2m €55,703 42.1% 1
APOTHEEK PLATEVOET Sint-Gillis-Waas €1.3m €57,085 96.0% -
APOTEEK ROGGEN Dilbeek €1.0m €71,877 54.7% -

These companies have the same main activity as APOTEEK ENGSBERGEN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1m and €1.3m, founded between 1979 and 1993.

Official details

Source: KBO
Status
Active since 01-08-1986Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.034.205.0143980 Tessenderlo-Ham, since 15-01-1987
Financial year end
31 December
Peppol
Reachable since 12-10-2025
Company details

Annual accounts 2025

≈ €340,000estimated
€1.3m▲ 135%
Filing
Filed on 30-08-2026
Financials

Insights on APOTEEK ENGSBERGEN

APOTEEK ENGSBERGEN files the abbreviated format. That format states no turnover. The gross margin rose from €44,127 in 2006 to €70,331 in 2025.

The balance sheet grew most in 2025 through fixed assets, financed with long-term debt.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTEEK ENGSBERGEN

What is the company number of APOTEEK ENGSBERGEN?
The company number of APOTEEK ENGSBERGEN is 0429.393.759. The VAT number is the same number with BE in front: BE 0429.393.759.
Where is APOTEEK ENGSBERGEN based?
The registered office is at Engsbergseweg 69, 3980 Tessenderlo-Ham.Company details
What does APOTEEK ENGSBERGEN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTEEK ENGSBERGEN?
APOTEEK ENGSBERGEN is a private limited company (BV).
When was APOTEEK ENGSBERGEN founded?
APOTEEK ENGSBERGEN was founded on 01-08-1986.
Is APOTEEK ENGSBERGEN still active?
Yes, APOTEEK ENGSBERGEN is an active enterprise in the KBO register.
What is the turnover of APOTEEK ENGSBERGEN?
The turnover in financial year 2025 is ≈ €340,000. This figure is estimated from the gross margin of €70,331 and 76 comparable companies (NACE 477). It probably lies between €170,000 and €490,000.Financials
Is APOTEEK ENGSBERGEN profitable?
In financial year 2025, APOTEEK ENGSBERGEN made a profit of €27,688.
Where can I find the annual accounts of APOTEEK ENGSBERGEN?
APOTEEK ENGSBERGEN filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTEEK ENGSBERGEN due?
APOTEEK ENGSBERGEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.